Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 257

Results For "ET"

10730 News Found

Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial
Clinical Trials | June 02, 2026

Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial

An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary


CellCarta and Leica Biosystems expand push to streamline precision medicine development
News | June 02, 2026

CellCarta and Leica Biosystems expand push to streamline precision medicine development

The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments


Ebola vax on the anvil?
News | June 02, 2026

Ebola vax on the anvil?

CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate


Yoginii partners with Panacea Biotec to expand wellness portfolio
Healthcare | June 02, 2026

Yoginii partners with Panacea Biotec to expand wellness portfolio

Collaboration brings Staart Prime, ChilRun and NikoMom products to Yoginii’s platform, strengthening its family-focused wellness ecosystem and supporting women through motherhood and family care


M|O|C Cancer Care’s research gains global recognition at ASCO 2026
Healthcare | June 02, 2026

M|O|C Cancer Care’s research gains global recognition at ASCO 2026

The accepted studies span several critical areas of oncology, including nutrition, genomics, precision medicine, patient-reported outcomes, and community-based cancer care


Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma
Drug Approval | June 02, 2026

Bristol Myers Squibb wins EU approval for Opdivo-based frontline treatment in advanced hodgkin lymphoma

The approval is supported by results from the Phase 3 SWOG 1826 trial


STRIDE-based regimens show survival momentum in EMERALD-3 liver cancer trial
Clinical Trials | June 02, 2026

STRIDE-based regimens show survival momentum in EMERALD-3 liver cancer trial

While overall survival data remain immature, the results pointed to a favourable trend.


Aragen scales Renaissance Pharma’s cancer antibody to commercial GMP in just 9 months
Biopharma | June 02, 2026

Aragen scales Renaissance Pharma’s cancer antibody to commercial GMP in just 9 months

Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru


AIIMS Delhi and Raipur use Intuitive’s tech to conduct tele-mentored robotic surgery
Hospitals | June 02, 2026

AIIMS Delhi and Raipur use Intuitive’s tech to conduct tele-mentored robotic surgery

Real-time remote collaboration during robotic-assisted cholecystectomy showcases new possibilities for surgical mentoring, education, and knowledge sharing across institutions


World No Tobacco Day: HCG Cancer Hospital Mumbai holds awareness campaigns
Hospitals | June 01, 2026

World No Tobacco Day: HCG Cancer Hospital Mumbai holds awareness campaigns

Initiatives at Churchgate Station and Mahindra & Mahindra focus on early detection, public education, and tobacco-related cancer prevention